Summary & Overview
CPT 33261: Surgical Ventricular Ablation with Cardiopulmonary Bypass
CPT code 33261 designates a cardiac surgical ablation targeting a focal ventricular arrhythmia performed with the patient on cardiopulmonary bypass. The procedure is clinically significant because it addresses life‑threatening ventricular rhythms that may not be controlled by catheter-based approaches, and it typically requires an operating room and cardiothoracic surgical resources. Nationally, procedures of this type influence hospital resource utilization, perioperative cardiac care pathways, and coverage discussions for advanced electrophysiologic and surgical therapies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context and service setting for CPT code 33261, a summary of payer coverage considerations and common modifier usage where available, and guidance on where to find relevant policy and coding updates. The publication also provides benchmarking and utilization framing where data exists and notes when specific items are not provided.
This summary is intended for coding professionals, practice managers, and clinical leaders seeking a national overview of the code’s clinical meaning, typical site of service, and the payer landscape relevant to surgical ventricular ablation performed with cardiopulmonary bypass.
Billing Code Overview
CPT code 33261 describes a surgical procedure in which the provider destroys a small area of the heart ventricle responsible for an abnormal heart rhythm while the patient is supported on cardiopulmonary bypass. This is a targeted cardiac ablation performed during an operative intervention.
-
Service type: Cardiac surgical ablation under cardiopulmonary bypass
-
Typical site of service: Inpatient operating room or cardiac surgery suite with cardiopulmonary bypass capability
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old man with ischemic cardiomyopathy who presents with recurrent, drug-refractory ventricular tachycardia (VT) causing presyncope despite antiarrhythmic therapy and prior endocardial ablation attempts. Preoperative workup includes transthoracic and transesophageal echocardiography to assess ventricular function and structural lesions, cardiac MRI to localize scar substrate when feasible, and electrophysiology study mapping to identify the arrhythmogenic focus. The multidisciplinary team (electrophysiology, cardiothoracic surgery, anesthesiology, perfusion) plans a surgical ventricular tachycardia ablation with placement of the patient on cardiopulmonary bypass.
In the operating room under general anesthesia, the cardiothoracic surgeon performs a median sternotomy or limited thoracotomy. Cardiopulmonary bypass is instituted and myocardial exposure achieved. Electrophysiologic mapping (epicardial and/or endocardial as indicated) and intraoperative stimulation identify the target ventricular tissue. The surgeon destroys the arrhythmogenic focus by cryoablation or surgical resection/endo-epicardial ablation while on bypass. Hemostasis is confirmed, the patient is weaned from bypass, and postoperative care includes telemetry monitoring in a cardiac ICU, assessment for recurrence, and management of anticoagulation and heart failure therapies as needed.
Typical site of service: Inpatient operating room (cardiothoracic surgery) with postoperative ICU stay.
Service type: Open surgical ventricular arrhythmia ablation performed on cardiopulmonary bypass.
Coding Specifications
| Modifier | Description | When to Use |
|---|